Description

MyHep DVir (Daclastasvir 60mg/Sofosbuvir 400mg)

MyHep DVIR™ is a fixed-dose combination licensed generic of Sovaldi® + Daklinza® produced in an FDA approved manufacturing facility in India. It’s a direct-acting antiviral (DAA) medication used to treat chronic Hepatitis C across all genotypes. For most patients, 12 weeks of treatment is needed to reach cure.

Bottle Size : 28 Tablets (4 weeks supply)

Active Ingredients : Sofosbuvir 400 mg + Daclatasvir 60 mg

Produced by Mylan Pharmaceuticals®

Description Credit: Link